Sol-Gel Technologies (SLGL) Current Assets (2016 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Current Assets came in at $55.8 million in Q1 2026, up 138.09% year-on-year from $23.4 million in Q1 2025, and up 106.85% on a QoQ basis from $27.0 million in Q4 2025.
Sol-Gel Technologies (SLGL) Current Assets (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 11 years of Current Assets data on file, last reported at $55.8 million in Q1 2026.
- On a quarterly basis, Current Assets rose 138.09% year-over-year to $55.8 million in Q1 2026; TTM through Mar 2026 was $55.8 million, a 138.09% increase from a year earlier, with the FY2025 full-year figure at $27.0 million, down 13.82% from the prior year.
- Current Assets for Q1 2026 stood at $55.8 million, up from $27.0 million in the prior quarter.
- Over the last five years, Current Assets for SLGL reached as high as $55.8 million in Q1 2026 and fell as low as $23.4 million in Q1 2025.
- Historically, Current Assets has averaged $40.1 million across 5 years, with a median of $40.7 million in 2023.
- Across the five-year window, Current Assets sank 34.92% in 2025 and soared 138.09% in 2026, its largest moves.
- Year by year, Current Assets stood at $43.1 million in 2022, then retreated by 4.39% to $41.2 million in 2023, then fell by 23.98% to $31.3 million in 2024, then slipped by 13.82% to $27.0 million in 2025, then surged by 106.85% to $55.8 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $55.8 million in Q1 2026, $27.0 million in Q4 2025, and $31.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | 55.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.79 Mn |
| Dec 31, 2025 | 26.97 Mn |
| Sep 30, 2025 | 31.65 Mn |
| Jun 30, 2025 | 36.26 Mn |
| Mar 31, 2025 | 23.43 Mn |
| Dec 31, 2024 | 31.30 Mn |
| Sep 30, 2024 | 37.95 Mn |
| Jun 30, 2024 | 38.28 Mn |
| Mar 31, 2024 | 36.01 Mn |
| Dec 31, 2023 | 41.17 Mn |
| Sep 30, 2023 | 45.47 Mn |
| Jun 30, 2023 | 51.59 Mn |
| Mar 31, 2023 | 40.68 Mn |
| Dec 31, 2022 | 43.06 Mn |
| Sep 30, 2022 | 47.56 Mn |
| Jun 30, 2022 | 48.48 Mn |
| Mar 31, 2022 | 46.72 Mn |
| Dec 31, 2021 | 57.11 Mn |
| Sep 30, 2021 | 48.15 Mn |
| Jun 30, 2021 | 41.39 Mn |